Univ. of Pittsburgh Medical Center leads group buying PPL'S cloning, stem cell business

e-knockout pigs will likely produce up to 40 more double-knockout pigs by the end of this summer.

To operate its xenotransplantation and other businesses, Regenecor Holdings has formed two subsidiaries. Regenecor Inc. of Virginia retains PPL's existing work force and infrastructure in Blacksburg, where all current work will continue, including the expansion of its cloned pig herd for xenotransplantation. Regenecor (PA), Inc. will carry out pivotal animal and clinical studies involving pancreatic islets cells and whole organs.

Such studies will commence after review by appropriate government bodies and will only involve clinical studies in accordance with federal guidelines. Following these and other studies, Regenecor-sponsored human xenotransplant trials could take place at UPMC at some point in the future.

Regenecor Holdings will be governed by a board of directors with Amadeo Marcos, M.D., professor of surgery and clinical director of transplantation at the Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine, as its chairman. David Ayares, Ph.D., formerly COO and vice president of research at PPL, has been named CEO of Regenecor Inc. and a member of the board of Regenecor Holdings. Thomas E. Starzl, M.D., Ph.D., professor of surgery at Pitt's School of Medicine, will chair the company's scientific advisory board.

In addition to the 24 employed in Virginia, Regenecor will draw upon the talent and resources of leading scientists at the University of Pittsburgh and other institutions through various collaborations. Over time, new jobs could be generated in both Virginia and Pittsburgh.

To support Regenecor's Pittsburgh-based start-up operations, the Pittsburgh Life Sciences Greenhouse has committed $100,000 for the purpose of rental support and capital equipment expenses. The commitment recognizes Regenecor's potential to stimulate job growth and enhance the region's life sciences an

Contact: Lisa Rossi
University of Pittsburgh Medical Center

Page: 1 2 3 4 5

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Univ. of Pittsburgh receives $6.3M NIH grant to study oral health disparities in Appalachia
3. Univ. of Fla. professor: Air cleaning system destroys Anthrax, other pathogens
4. University of Pittsburgh receives $10 million grant for head and neck cancer
5. University of Pittsburgh medical center among first to implant heart assist device
6. University of Pittsburgh receives NIH funding to develop heart assist device for infants
7. Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon
8. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
9. Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model
10. Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers
11. University of Pittsburgh scientist honored for major accomplishment in cancer research

Post Your Comments:

(Date:1/8/2019)... Denmark and RALEIGH, N.C. (PRWEB) , ... January ... ... in micro acoustic and micro mechanical technologies and solutions for hearing instruments and ... technology, today announced BiometRIC, the first ever hearing aid receiver in canal with ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... culture models into their drug discovery research workflows with biology ranging from single ... vivo relevancy of in vitro studies, they create several challenges that need to ...
(Date:12/22/2018)... , ... December 21, 2018 , ... ... sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China ... from China.” , The discussion was moderated by patent attorney David J. ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... With the U.S. Congress designating January as ... transmitted disease (STD) testing service, today announces tips to help reduce the risk of Cervical ... Human Papillomavirus (HPV). Genital HPV is the #1 most common STD and an ...
(Date:1/10/2019)... ... January 08, 2019 , ... Rascal was adopted from a local shelter when he was ... mixed breed.” Unfortunately, just six weeks after he was adopted, he tore his right ... to form in the joint after such a traumatic injury. , Sure enough, when Rascal ...
(Date:1/8/2019)... ... January 07, 2019 , ... ... members into Noninvasix. This represents the second investment AngelMD has made into Noninvasix ... morbidity, Noninvasix is developing a patient monitor to directly, accurately, and noninvasively measure ...
(Date:1/4/2019)... ... January 04, 2019 , ... Triangle Insights ... to the firm. Ted will be joining the firm as a partner. ... consulting services to the pharmaceutical industry. At Triangle Insights, Ted will apply his ...
Breaking Biology Technology:
Cached News: